Nasdaq:US$13.74 (-0.46) | HKEX:HK$22.10 (-1.00) | AIM:£2.34 (+0)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 23 Dec 2014

Discovery of fruquintinib, a potent and highly selective small molecule inhibitor of VEGFR 1,2,3 tyrosine kinases for cancer therapy (Cancer Biology & Therapy 2014)